Related Experiment Video

Updated: Aug 9, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

[Respiratory infection due to Chlamydia trachomatis in infants. Clinical presentation and outcome in 18 patients]

M A Marín Gabriel1, S de las Heras Ibarra, E Bergón Sendín

  • 1Seccion de Inmunodeficiencia, Hospital 12 de Octubre, Madrid, Spain.

Anales De Pediatria (Barcelona, Spain : 2003)
|March 23, 2004
PubMed

Insights

Chlamydia trachomatis can cause serious lower respiratory tract disease in infants under six months. Early diagnosis and treatment are crucial, as infection may require hospitalization and intensive care.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Bacteriology

Context:

  • Chlamydia trachomatis is a common bacterial pathogen.
  • It causes various infections in men, women, and children.
  • In infants, it can lead to conjunctivitis and lower respiratory tract disease.

Purpose:

  • To highlight the potential severity of Chlamydia trachomatis lower respiratory tract disease in infants.
  • To emphasize the need for increased awareness and prompt diagnosis.

Summary:

  • A retrospective review identified 18 infants under 6 months with C. trachomatis lower respiratory tract disease.
  • 17 infants required hospitalization, and 5 needed pediatric intensive care.
  • Symptoms included apnea and interstitial infiltrates on chest X-ray; all infants recovered with erythromycin treatment.

Impact:

  • C. trachomatis infection should be considered in infants presenting with lower respiratory tract symptoms, especially when other pathogens are absent.
  • This underscores the importance of ruling out C. trachomatis in hospitalized infants with respiratory distress.
  • Prompt identification and treatment can prevent severe outcomes and reduce hospital stays.
Abstract

More Related Videos

Forward Genetic Approaches in Chlamydia trachomatis09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow10:44

Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow

Published on: August 15, 2025

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...